R. Walker

发表

Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer

S. Duffy, A. Howell, I. Dos Santos Silva, 2013, Breast Cancer Research.

Estrogen Alters the Splicing of Type 1 Corticotropin-Releasing Hormone Receptor in Breast Cancer Cells

R. Walker, A. Tyson-Capper, D. Grammatopoulos, 2013, Science Signaling.

World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs

R. Walker, R A Walker, 2005 .

Altered expression of anti-apoptotic proteins in non-involved tissue from cancer-containing breasts

R. Walker, A. Batchelder, A. Gordon-Weeks, 2009, Breast Cancer Research and Treatment.

The complexities of breast cancer desmoplasia

R. Walker, Rosemary A Walker, 2001, Breast Cancer Research.

Can biological markers improve the management of breast cancer patients?

M. Dowsett, J. Robertson, R. Nicholson, 2000, British Journal of Cancer.

Parathyroid hormone related protein and hypercalcaemia in breast cancer.

J. Ratcliffe, J. M. Morrison, R. Walker, 1991, BMJ.

Influence of the Tumour Microenvironment

R. Walker, 2009 .

Best Practice No 176

I. Ellis, M. Dowsett, S. Humphreys, 2004, Journal of Clinical Pathology.

A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer

Lucy F. Stead, I. Ellis, S. Shousha, 2016, Clinical Cancer Research.

Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas.

W. J. Brammar, D. Lane, J. Varley, 1991, Oncogene.

Cyclooxygenase-2 expression is a novel prognostic factor in malignant mesothelioma.

K. O'Byrne, K. Abrams, D. Waller, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Angiogenesis is an independent prognostic factor in malignant mesothelioma

K. O'Byrne, D. Waller, R. Walker, 2001, British Journal of Cancer.

Does immunointensity account for the differences in prognostic significance of Bcl-2 expression in non-small cell lung cancer?

K. Abrams, W. Steward, R. Walker, 2009, Pathology & Oncology Research.

Sporadic breast cancer in young women: Prevalence of loss of heterozygosity at p53, BRCA1 and BRCA2

Suzanne M Johnson, R. Walker, J. Shaw, 2002, International journal of cancer.

The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumours.

W. J. Brammar, B. Ponder, A. Jeffreys, 1989, Oncogene.

Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms

J. Pringle, D. Edwards, C. Pennington, 2009, Breast Cancer Research.

Differential expression of translation-associated genes in benign and malignant human breast tumours.

W. J. Brammar, J. Varley, R. Walker, 1992, British Journal of Cancer.

Assessment of milk fat globule membrane antibodies and lectins as markers of short-term prognosis in breast cancer.

R. Walker, RA Walker, 1990, British Journal of Cancer.

Parathyroid hormone related protein and skeletal morbidity in breast cancer.

J. Warwick, J. Ratcliffe, J. M. Morrison, 1992, European journal of cancer.

The localization of laminin mRNA and protein in the postimplantation embryo and placenta of the mouse: an in situ hybridization and immunocytochemical study.

J. Varley, R. Walker, D. Critchley, 1988, Development.

Is apocrine differentiation in breast carcinoma of prognostic significance?

W. Miller, H. Stewart, R. Walker, 1990, British Journal of Cancer.

An immunohistochemical study of the tissue distribution of the breast cyst fluid protein, zinc alpha2 glycoprotein

W. Miller, R. Walker, N. Bundred, 1987, Histopathology.

Biological markers: maintaining standards

M. Dowsett, J. Robertson, R. Nicholson, 2000, British Journal of Cancer.

The binding of peroxidase‐labelled lectins to human breast epithelium. III—altered fucose‐binding patterns of breast carcinomas and their significance

R. Walker, 1984, The Journal of pathology.

The binding of peroxidase‐labelled lectins to human breast epithelium. II—the reactivity of breast carcinomas to wheat germ agglutinin

R. Walker, 1984, The Journal of pathology.

The Importance of Careful Blood Processing in Isolation of Cell‐Free DNA

R. C. Coombes, R. Walker, M. Slade, 2006, Annals of the New York Academy of Sciences.

Oncogene organisation and expression: prediction in breast cancer.

W. J. Brammar, J. Varley, R. Walker, 1989, Hormone research.

Modulation of cell surface componts of human breast cancer cells by retinoic acid: Enhanced HLA‐DR Expression

R. Walker, F. J. Gardner, F. J. E. Gardner, 1993, The Journal of pathology.

Analysis of glycoproteins released from benign and malignant human breast: changes in size and fucosylation with malignancy.

R. Walker, P. Rye, 1989, European journal of cancer & clinical oncology.

Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas

R. Walker, A. Kovács, J. Dhillon, 2003, Molecular pathology : MP.

Comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester.

B. Sibai, R. Andersen, B. Mercer, 1998, American journal of obstetrics and gynecology.

Allelic imbalance on chromosome I in human breast cancer. I. Minisatellite and rflp analysis

W. J. Brammar, J. Varley, J. Armour, 1995, Genes, Chromosomes and Cancer.

Mucoid carcinomas of the breast: a study using mucin histochemistry and peanut lectin

R. Walker, 1982, Histopathology.

Biochemical analysis of breast cyst fluid predicts the natural history of breast cysts

N. Bundred, R. Walker, A. Winder, 1992 .

Immunohistological localization of pregnancyassociated endometrial α2‐globulin (α2‐PEG) in endometrial adenocarcinoma and effect of medroxyprogesterone acetate

S. Bell, J. Macvicar, R. Walker, 1988 .

Tumour markers predictive of successful treatment of breast cancer with primary endocrine therapy in patients over 70 years old: a prospective study.

R. Walker, A. Stotter, 2010, Critical reviews in oncology/hematology.

HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods

I. Ellis, S. Pinder, B. Jasani, 2011, Journal of Clinical Pathology.

Are all ductal proliferations of the breast premalignant?

R. Walker, 2001, The Journal of pathology.

A Multi-Centre Investigation Towards Reaching a Consensus on the Immunohistochemical Detection of ERβ in Archival Formalin-ﬁxed Paraffin Embedded Human Breast Tissue

V. Speirs, P. Carder, C. Witton, 2005, Breast Cancer Research and Treatment.

Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast.

J. Varley, R. Walker, K. Munn, 1995, Oncogene.

Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast

R. Walker, J. Zuk, John A. Zuk, 1987, The Journal of pathology.

West Midlands Oncology Association trial of adjuvant chemotherapy in node-negative breast cancer.

A. Howell, J. Waterhouse, J. M. Morrison, 1992, Journal of the National Cancer Institute. Monographs.

Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.

W. J. Brammar, J. Varley, R. Walker, 1987, Oncogene.

The erbB/HER type 1 tyrosine kinase receptor family

R. Walker, 1998, The Journal of pathology.

The utilization of [3H] sugars by non‐malignant and malignant human breast

R. Walker, P. Sanderson, S. Day, 1986, The Journal of pathology.

The use of lectins in histopathology

R. Walker, 1985, Pathology, research and practice.

Ulex europeus I—peroxidase as a marker of vascular endothelium: Its application in routine histopathology

R. Walker, 1985, The Journal of pathology.

Relationship of transforming growth factor beta 1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma.

R. Walker, B. Gallacher, Rashidra R. Walker, 1994, British Journal of Cancer.

Oestrogen receptor and its potential role in breast cancer development

R. Walker, 1999, The Journal of pathology.

Alteration of stromal protein and integrin expression in breast—a marker of premalignant change?

R. Walker, D. Critchley, J. Jones, 1992, The Journal of pathology.

Decreased apoptosis in non‐involved tissue from cancer‐containing breasts

R. Walker, H. Hassan, Howayda I. Hassan, 1998, The Journal of pathology.

Oestrogen receptor, epidermal growth factor receptor and oncoprotein expression in non-involved tissue of cancerous breasts

J. Cowl, R. Walker, J. Jones, 1992 .

Effect of prolactin on lactalbumin production by normal and malignant human breast tissue in organ culture.

A. Howell, K. Woods, R. Walker, 1980, Cancer Research.

Expression of the pS2 peptide in normal human glandular endometrium during the menstrual cycle: a possible function.

R. Walker, K. Dookeran, P. Rye, 1993, Disease markers.

Integrins: a role as cell signalling molecules.

R. Walker, J. Jones, J. Jones, 1999, Molecular pathology : MP.

Immunohistochemical evaluation of tumours.

R. Walker, 1989, Current opinion in immunology.

The cytochemical demonstration of oestrogen receptors in human breast carcinomas

R. Walker, 1981, The Journal of pathology.

Monoclonal antibody LU-BCRU-G7 against a breast tumour-associated glycoprotein recognizes the disaccharide Gal beta 1-3GlcNAc.

N. Bovin, R. Walker, P. Rye, 1995, Glycobiology.

The binding of peroxidase‐labelled lectins to human breast epithelium. IV—the reactivity of breast carcinomas to peanut, soy bean and Dolichos biflorus agglutinins

R. Walker, 1985, The Journal of pathology.

The histopathological evaluation of nucleolar organizer region proteins

R. Walker, 1988, Histopathology.

Expression of the antigen detected by the monoclonal antibody Ca 19.9 in human breast tissues

R. Walker, S. Day, 2004, Virchows Archiv A.

Lectin binding and steroid receptors in human breast carcinomas

W. Miller, R. Walker, R. Hawkins, 1985, The Journal of pathology.

The binding of peroxidase‐labelled lectins to human breast epithelium i—normal, hyperplastic and lactating breast

R. Walker, 1984, The Journal of pathology.

The binding of fluorescent‐labelled concanavalin A to human breast tissue—A marker of differentiation

R. Walker, 1983, The Journal of pathology.

Confirmation of the copy number of chromosome 1 in interphase nuclei from paraffin sections of breast tumours by fluorescencein situ hybridization

W. J. Brammar, J. Varley, R. Walker, 1995, Chromosome Research.

There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions

J. Pringle, R. Walker, J. Jones, 2003, Journal of clinical pathology.

The demonstration of α lactalbumin in human breast carcinomas

R. Walker, 1979 .

The synthesis of the glycoprotein hormone α subunit by human breast carcinomas

A. Howell, D. Cove, R. Walker, 1979 .

Significance of alpha-subunit HCG demonstrated in breast carcinomas by the immunoperoxidase technique.

R. Walker, 1978, Journal of clinical pathology.

The expression of fucosylated type 2 blood group chains in human breast and their significance

R. Walker, S. Day, 1986, The Journal of pathology.

Biological markers in human breast carcinoma

R. Walker, 1982, The Journal of pathology.

Carcinoembryonic antigen (CEA) in explants of human breast cancer: comparison of immunohistochemical detection and release during short-term culture.

C. Sturgeon, W. Miller, R. Walker, 1983, British Journal of Cancer.

Demonstration of carcinoembryonic antigen in human breast carcinomas by the immunoperoxidase technique.

R. Walker, 1980, Journal of clinical pathology.

Immunohistochemical expression of tumour-associated glycoprotein and polymorphic epithelial mucin in the human endometrium during the menstrual cycle.

S. Bell, R. Walker, P. Rye, 1993, Journal of reproduction and fertility.

Prognostic value of a breast cancer-associated glycoprotein detected by monoclonal antibody LU-BCRU-G7.

R. Walker, P. Rye, 1994, European journal of cancer.

The histochemistry of glycosidases in human benign and malignant breast tissue

R. Walker, 1984, The Journal of pathology.

Helix pomatia and prognosis of breast cancer.

R. Walker, 1993, British Journal of Cancer.

The -308.1 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLA-B27.

R. Walker, M. Field, F. McGarry, 1999, The Journal of rheumatology.

Breast myoepithelium—the ignored cell

R. Walker, 1988, The Journal of pathology.

Quantification of immunohistochemistry—issues concerning methods, utility and semiquantitative assessment I

R. Walker, R A Walker, 2006, Histopathology.

Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours

J. Minna, M. Lerman, J. Rader, 2001, Oncogene.

Intrinsic genetic characteristics determine tumor-modifying capacity of fibroblasts: matrix metalloproteinase-3 5A/5A genotype enhances breast cancer cell invasion

R. Walker, S. Hughes, J. Jones, 2007, Breast Cancer Research.

The expression of c‐fos protein in human breast

J. Cowl, R. Walker, 1991, The Journal of pathology.

Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas.

T. Walsh, J. Shaw, S. Chappell, 1997, British Journal of Cancer.

Tumour specific promoter region methylation of the human homologue of the Drosophila Roundabout gene DUTT1 (ROBO1) in human cancers

J. Minna, Y. Sekido, E. Maher, 2002, Oncogene.

Loss of heterozygosity on the X chromosome in human breast cancer

W. J. Brammar, J. Varley, J. Armour, 1995, Genes, chromosomes & cancer.

Detection of HER2 amplification in circulating free DNA in patients with breast cancer

J. Shaw, R. Walker, K. Blighe, 2011, British Journal of Cancer.

Breast carcinomas occurring in young women (< 35 years) are different.

R. Walker, M. Webb, S. Dearing, 1996, British Journal of Cancer.

Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor gene correlates with poor differentiation in early breast carcinomas.

T. Walsh, S. Chappell, R. Walker, 1997, British Journal of Cancer.

Allelic imbalance in the region of the BRCA1 gene in ductal carcinoma in situ of the breast.

J. Varley, R. Walker, L. Menasce, 1996, British Journal of Cancer.

Current issues in diagnostic breast pathology

I. Ellis, S. Pinder, R. Walker, 2012, Journal of Clinical Pathology.

Transforming growth factor beta 1 in ductal carcinoma in situ and invasive carcinomas of the breast.

R. Walker, S. Dearing, 1992, European Journal of Cancer.

Expression of p53 protein in infiltrating and in‐situ breast carcinomas

D. Lane, J. Varley, R. Walker, 1991, The Journal of pathology.

A sequence previously identified as metastasis-related encodes an acidic ribosomal phosphoprotein, P2.

W. J. Brammar, J. Varley, R. Walker, 1990, British Journal of Cancer.

West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: results after a median follow-up of 7 years. I. Patients with involved axillary lymph nodes.

A. Howell, J. Waterhouse, J. M. Morrison, 1989, British Journal of Cancer.

An evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancer.

J. Varley, W. Gullick, R. Walker, 1989, British Journal of Cancer.

p21 ras protein expression in benign and malignant

R. Walker, Nafisa Wilkinson, 1988, The Journal of pathology.

HLA class II sublocus expression in benign and malignant breast epithelium

R. Walker, John A. Zuk, J. Zuk, 1988, The Journal of pathology.

Comparison of monoclonal antibody Ki-67 reactivity with grade and DNA flow cytometry of breast carcinomas.

R. Camplejohn, R. Walker, 1988, British Journal of Cancer.

The assessment of in vitro modulation of milk fat globule membrane expression by human breast carcinomas

R. Walker, J. Jones, J. L. Jones, 1987, The Journal of pathology.

Differential expression of cellular oncogenes in benign and malignant human breast tissue

J. Varley, R. Walker, Joanne L. Whittaker, 1986, International journal of cancer.

DNA flow cytometry of human breast carcinomas and its relationship to transferrin and epidermal growth factor receptors

R. Camplejohn, R. Walker, 1986, The Journal of pathology.

Genomic analysis of circulating cell-free DNA infers breast cancer dormancy.

Karen Page, Kevin Blighe, R Charles Coombes, 2012, Genome research.

Microsatellite alterations plasma DNA of primary breast cancer patients.

T. Walsh, R. Walker, L. Primrose, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Modulation of myoepithelial-associated alpha6beta4 integrin in a breast cancer cell line alters invasive potential.

R. Walker, D. Critchley, J. Jones, 1997, Experimental cell research.

Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients

R. Walker, J. Luckett, Rashidra R. Walker, 2007, British Journal of Cancer.

Isolation and characterization of a novel gene with differential expression in benign and malignant human breast tumours.

W. J. Brammar, J. Varley, R. Walker, 1992, Human molecular genetics.

Expression of epidermal growth factor receptor mRNA and protein in primary breast carcinomas

R. Walker, S. Dearing, 2004, Breast Cancer Research and Treatment.

Breast cell invasive potential relates to the myoepithelial phenotype

R. Walker, M. Adams, K. Mulligan, 2003, International journal of cancer.

Changes in tenascin-C isoform expression in invasive and preinvasive breast disease.

S. Bell, J. Pringle, R. Walker, 2002, Cancer research.

Angiogenesis and non-small cell lung cancer.

K. O'Byrne, W. Steward, R. Walker, 2000, Lung cancer.

Immunohistological distribution of the secretory endometrial protein, 'pregnancy-associated endometrial alpha 2-globulin', a glycosylated beta-lactoglobulin homologue, in the human fetus and adult employing monoclonal antibodies.

S. Bell, R. Walker, G. Waites, 1990, Human reproduction.

Serum levels of pregnancy-associated endometrial α-globulin ( α-PEG) during normal menstrual and combined oral contraceptive cycles and relationship to immunohistologiacl localization

S. Bell, R. Walker, P. Wood, 1989 .

Differential expression of the mitochondrial gene cytochrome oxidase ii in benign and malignant breast tissue

W. J. Brammar, J. Varley, R. Walker, 1992, The Journal of pathology.

Clinical and functional significance of α9β1 integrin expression in breast cancer: a novel cell‐surface marker of the basal phenotype that promotes tumour cell invasion

C. Chelala, A. Brentnall, S. Dreger, 2011, The Journal of pathology.

HISTOLOGICAL DETECTION OF ŒSTROGEN RECEPTOR IN HUMAN BREAST CARCINOMAS

A. Howell, D. Cove, R. Walker, 1980, The Lancet.

Histological detection of oestrogen receptor in human breast carcinomas.

A. Howell, D. Cove, R. Walker, 1980, Lancet.

E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma.

R. Walker, J. Jones, Jl Jones, 1996, British Journal of Cancer.

Expression of tenascin-C and its isoforms in the breast

J. Pringle, R. Walker, D. Guttery, 2010, Cancer and Metastasis Reviews.

Prognostic significance of platelet and microvessel counts in operable non-small cell lung cancer.

K. O'Byrne, W. Steward, R. Walker, 2000, Lung cancer.

A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences

G. Ball, S. Shousha, E. Provenzano, 2012, Breast Cancer Research and Treatment.

Impact of a national external quality assessment scheme for breast pathology in the UK

I. Ellis, S. Humphreys, S. Pinder, 2006, Journal of Clinical Pathology.

Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features

E. Maher, R. Walker, A. Martínez, 2001, Molecular pathology : MP.

Expression of oestrogen receptor alpha variants in non‐malignant breast and early invasive breast carcinomas

Suzanne M Johnson, R. Walker, J. Shaw, 2000, The Journal of pathology.

Lack of cyclin E immunoreactivity in non-malignant breast and association with proliferation in breast cancer.

K. Scott, R. Walker, 1997, British Journal of Cancer.

An immunohistochemical and in situ hybridization study of c‐myc and c‐erbB‐2 expression in primary human breast carcinomas

J. Varley, R. Walker, D. Critchley, 1989, The Journal of pathology.

Molecular pathology of breast cancer and its application to clinical management

Tom Walsh, Stephen Chappell, T. Walsh, 1997, Cancer and Metastasis Reviews.

Ultrastructural localization of milk fat globule membrane antigens in human breast carcinomas

R. Walker, D. Corcoran, 1990, The Journal of pathology.

Determination of transforming growth factor beta1 mRNA expression in breast carcinomas by in situ hybridization

R. Walker, B. Gallacher, 1995, The Journal of pathology.

Expression of the pS2 peptide in primary breast carcinomas: Comparison of membrane and cytoplasmic staining patterns

R. Walker, K. Dookeran, P. Rye, 1993, The Journal of pathology.

In vitro modulation of cellular localization of milk fat globule membrane antigens in human breast carcinomas

R. Walker, D. Corcoran, J. L. Jones, 1991, The Journal of pathology.

Post embedding immunoelectron microscopy of human breast cancer: a comparison of three acrylic resins

R. Walker, D. Corcoran, 1990, The Histochemical Journal.

Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas

J. Mosquera, R. Walker, Juan-Miguel Mosquera, 2002, The Journal of pathology.

The significance of argyrophilia in human breast carcinomas

R. Walker, J. McCutcheon, 2004, Virchows Archiv A.

Altered expression of epidermal growth factor receptor in non-involved tissue of cancer-containing breasts.

R. Walker, H. Hassan, H. I. Hassan, 2001, Breast.

Recommendations for HER2 testing in the UK

I. Ellis, M. Dowsett, B. Gusterson, 2000, Journal of clinical pathology.

HER2 testing in the UK: further update to recommendations

I. Ellis, M. Dowsett, S. Pinder, 2008, Journal of Clinical Pathology.

Updated recommendations for HER2 testing in the UK

Anthony Rhodes, Ian O. Ellis, Bharat Jasani, 2004 .

HER2 testing in the UK: consensus from a national consultation

R. Laing, M. Dowsett, R. Walker, 2007, Journal of Clinical Pathology.

recommendationstesting in the UK: further update to

I. Ellis, M. Dowsett, S. Pinder, 2008 .

Immunohistochemical markers as predictive tools for breast cancer

R. Walker, 2007, Journal of Clinical Pathology.

Immunohistochemical detection of steroid receptors in breast cancer: a working protocol

D Barnes, T Anderson, S. Pinder, 2000, Journal of clinical pathology.

Microglandular adenosis or microglandular adenoma? A molecular genetic analysis of a case associated with atypia and invasive carcinoma

Alan Mackay, Narinder Tamber, Alan Ashworth, 2009, Histopathology.

The localization of prolactin binding sites in human breast tissue

R. Walker, M. S. Dhadly, Mandeep Dhadly, 1983, International journal of cancer.

Assessment of HER2 status in breast cancer: why, when and how?

M. Dowsett, B. Gusterson, I. Ellis, 2000, European journal of cancer.

Comparison of pS2 and cathepsin D in primary breast carcinomas

R. Walker, K. Dookeran, R. Rajakariar, 1995 .

Use and assessment of diagnostic and predictive markers in breast pathology

R. Walker, 2007 .

Differentiation of human breast carcinomas: An immunohistological study of appropriate and inappropriate protein production

R. Walker, 1981, The Journal of pathology.

EDITORIAL. ANGIOGENESIS AND BREAST CANCER PROGNOSIS—A CONTINUING ISSUE

R. Walker, 1996, The Journal of pathology.

Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas

R. Walker, A. Kovács, J. Dhillon, 2003 .

Expression of MMP‐2 and MMP‐9, their inhibitors, and the activator MT1‐MMP in primary breast carcinomas

P. Glynn, R. Walker, J. L. Jones, 1999, The Journal of pathology.

Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ.

J. Varley, R. Walker, L. Menasce, 1996, British Journal of Cancer.

Control of matrix metalloproteinase activity in cancer

R. Walker, J. L. Jones, A. Walker, 1997, The Journal of pathology.

An open-label study of lapatinib in women with HER-2-negative early breast cancer: the lapatinib pre-surgical study (LPS study).

S. Shousha, E. Lam, J. Stebbing, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Microsatellite instability in ductal carcinoma in situ of the breast

T. Walsh, J. Shaw, S. Chappell, 1998, The Journal of pathology.

Observer agreement comparing the use of virtual slides with glass slides in the pathology review component of the POSH breast cancer cohort study

Darren Treanor, Kevin Wheeler, Diana M Eccles, 2012, Journal of Clinical Pathology.

The NHS breast screening programme (pathology) EQA: experience in recent years relating to issues involved in individual performance appraisal

I. Ellis, S. Humphreys, S. Pinder, 2006, Journal of Clinical Pathology.

Comparison of pathological and biological features of symptomatic and mammographically detected ductal carcinoma in situ of the breast.

R. Walker, R A Walker, S J Dearing, 1999, Human pathology.

β2‐Microglobulin in non‐malignant and malignant human breast: A feature of differentiation

R. Walker, K. Sidky, 1984, The Journal of pathology.

Differences between human breast cell lines in susceptibility towards growth inhibition by genistein

L. Howells, A. Gescher, M. Manson, 2001, British Journal of Cancer.

Immunohistochemical demonstration of carcinoembryonic antigen.

J. Macartney, R. Walker, 1979, Journal of clinical pathology.

Microsatellite instability in early sporadic breast cancer.

T. Walsh, J. Shaw, S. Chappell, 1996, British Journal of Cancer.

The Use of Peroxidase-labelled Hormones in the Study of Steroid Binding in Breast Carcinomas

R. Walker, 1982 .

P-cadherin as a marker in the differential diagnosis of breast lesions

R. Walker, A. Kovács, 2003, Journal of clinical pathology.

[Immunohistochemical study of P-cadherin in breast cancer].

L. Jones, R. Walker, A. Kovács, 2002, Orvosi hetilap.

Microsatellite Alterations in Plasma DNA of Primary Breast Cancer Patients 1

Suzanne M Johnson, T. Walsh, R. Walker, 2000 .

Immunohistological localization of human endometrial secretory protein, 'pregnancy-associated endometrial α2-globulin' (α2-PEG), during the menstrual cycle

S. Bell, R. Walker, G. Waites, 1988 .

Immunohistological localization of human endometrial secretory protein, 'pregnancy-associated endometrial alpha 2-globulin' (alpha 2-PEG), during the menstrual cycle.

S. Bell, R. Walker, G. Waites, 1988, Journal of reproduction and fertility.

The significance of histological determination of HER-2 status in breast cancer.

R. Walker, 2000, Breast.

Transferrin receptor expression in non‐malignant and malignant human breast tissue

R. Walker, S. Day, 1986, The Journal of pathology.

Human 'pregnancy-associated endometrial alpha 1-globulin', a 32 kDa insulin-like growth factor-binding protein: immunohistological distribution and localization in the adult and fetus.

S. Bell, R. James, R. Walker, 1990, The Journal of endocrinology.

Association of invasion-promoting tenascin-C additional domains with breast cancers in young women

J. Pringle, R. Walker, S. Hughes, 2010, Breast Cancer Research.

NON-MALIGNANT AND MALIGNANT

R. Walker, P. R. Sanderson, 2005 .

Decreased apoptosis in non‐involved tissue from cancer‐containing breasts

R. Walker, Howayda I. Hassan, 1998, The Journal of pathology.

Alteration of integrin and stromal protein expression — A marker of pre-malignant change?

R. Walker, J. Jones, 1992 .

The molecular pathology of human breast cancer.

J. Varley, R. Walker, 1993, Cancer Surveys.

A sequence previously identified as metastasis-related encodes an acidic ribosomal phosphoprotein, P2.

W. J. Brammar, J. Varley, R. Walker, 1990, British Journal of Cancer.

New perspectives into the biological and clinical relevance of oestrogen receptors in the human breast

V. Speirs, R. Walker, R. Walker, 2007, The Journal of pathology.

Carcinoembryonic antigen (CEA) in explants of human breast cancer: comparison of immunohistochemical detection and release during short-term culture.

C. Sturgeon, W. Miller, R. Walker, 1983, British Journal of Cancer.

34. Pathological and immunohistochemical prognostic factors in clinically node-negative breast cancer patients receiving adjuvant tamoxifen (BR3002 trial)

S. Parnell, J. Dunn, G. Oates, 1995 .

Genomic analysis of circulating cell-free DNA infers breast cancer dormancy.

J. Stebbing, C. Palmieri, R. Walker, 2012, Genome research.

Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features

E. Maher, R. Walker, F. Latif, 2001, Molecular pathology : MP.

The Use of Milk-Protein Estimation to Assess the Effect of Hormones on Human Breast in Organ Culture

A. Howell, K. Woods, R. Walker, 1979 .

Estrogen Alters the Splicing of Type 1 Corticotropin-Releasing Hormone Receptor in Breast Cancer Cells

R. Walker, A. Tyson-Capper, D. Grammatopoulos, 2013, Science Signaling.